{rfName}
Di

Indexed in

License and use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Sanz, Inigo GarciaAuthorNunez, Miguel SampedroAuthor

Share

November 13, 2024
Publications
>
Article

Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

Publicated to:Frontiers in Endocrinology. 15 1336306- - 2024-03-01 15(), DOI: 10.3389/fendo.2024.1336306

Authors: Araujo-Castro, Marta; Parra, Paola; Rojas-Marcos, Patricia Martin; Fano, Miguel Paja; Boillos, Marga; Pascual-Corrales, Eider; Cano, Ana Maria Garcia; Ruiz-Sanchez, Jorge Gabriel; Delgado, Almudena Vicente; Hoyos, Emilia Gomez; Ferreira, Rui; Sanz, Inigo Garcia; Sala, Monica Recasens; Millan, Rebeca Barahona San; Cesar, Maria Jose Picon; Guardiola, Patricia Diaz; Perdomo, Carolina M; Manjon-Miguelez, Laura; Centeno, Rogelio Garcia; Rebollo Roman, Angel; Gracia Gimeno, Paola; Robles Lazaro, Cristina; Morales-Ruiz, Manuel; Calatayud, Maria; Furio Collao, Simone Andree; Meneses, Diego; Nunez, Miguel Sampedro; Quesada, Veronica Escudero; Ribas, Elena Mena; Sanchez, Alicia Sanmartin; Gonzalvo Diaz, Cesar; Lamas, Cristina; Tous, Maria del Castillo; Gotarredona, Joaquin Serrano; Michalopoulou Alevras, Theodora; Mateo, Eva Maria Moya; Hanzu, Felicia A

Affiliations

CIBEROBN, Madrid, Spain - Author
Clin Univ Navarra, Endocrinol & Nutr Dept, Pamplona, Spain - Author
Complejo Asistencial Univ Salamanca, Dept Hematol, Salamanca, Spain - Author
Hosp Clin Barcelona, Dept Biochem & Mol Genet CDB, IDIBAPS, Barcelona 08036, Spain - Author
Hosp Clin Barcelona, Endocrinol & Nutr Dept, IDIPAS, Barcelona, Spain - Author
Hosp Doce Octubre, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Gen Univ Alicante, Endocrinol & Nutr Dept, Alicante, Spain - Author
Hosp Joan 23, Endocrinol & Nutr Dept, Tarragona, Spain - Author
Hosp Reina Sofia, Endocrinol & Nutr Dept, Cordoba, Spain - Author
Hosp Royo Villanova, Endocrinol & Nutr Dept, Zaragoza, Spain - Author
Hosp Univ Albacete, Endocrinol & Nutr Dept, Albacete, Spain - Author
Hosp Univ Basurto, Endocrinol & Nutr Dept, OSI Bilbao Basurto, Bilbao, Spain - Author
Hosp Univ Castellon, Dept Endocrinol & Nutr, Castellon de La Plana, Castellon, Spain - Author
Hosp Univ Cent Asturias, Endocrinol & Nutr Dept, Oviedo, Spain - Author
Hosp Univ Doctor Josep Trueta Girona, Dept Gastroenterol, Girona, Spain - Author
Hosp Univ Doctor Peset, Nephrol Dept, Valencia, Spain - Author
Hosp Univ Fdn Jimenez Diaz, Dept Endocrinol & Nutr, Madrid, Spain - Author
Hosp Univ Gregorio Maranon, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Univ Infanta Leonor, Internal Med, Madrid, Spain - Author
Hosp Univ Infanta Sofia, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Univ La Paz, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Univ Princesa, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Univ Princesa, Gen & Digest Surg Dept, Madrid, Spain - Author
Hosp Univ Ramon & Cajal, Biochem Dept, Madrid, Spain - Author
Hosp Univ Ramon & Cajal, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Univ Rey Juan Carlos, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Univ Son Espases, Endocrinol & Nutr Dept, Palma De Mallorca, Spain - Author
Hosp Univ Toledo, Endocrinol & Nutr Dept, Toledo, Spain - Author
Hosp Univ Valladolid, Endocrinol & Nutr Dept, Valladolid, Spain - Author
Hosp Univ Virgen Macarena, Endocrinol & Nutr Dept, Seville, Spain - Author
Hosp Univ Virgen Victoria Malaga, Endocrinol & Nutr Dept, IBIMA, Dept Endocrinol & Nutr, Malaga, Spain - Author
Inst Invest Biomed Ramon & Cajal, IRYCIS, Madrid, Spain - Author
Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain - Author
Univ Basque Country, Med Dept, Bilbao, Spain - Author
See more

Abstract

Purpose:To compare the clinical and hormonal characteristics of patients with familial hyperaldosteronism (FH) and sporadic primary aldosteronism (PA). Methods: A systematic review of the literature was performed for the identification of FH patients. The SPAIN-ALDO registry cohort of patients with no suspicion of FH was chosen as the comparator group (sporadic group). Results: A total of 360 FH (246 FH type I, 73 type II, 29 type III, and 12 type IV) cases and 830 sporadic PA patients were included. Patients with FH-I were younger than sporadic cases, and women were more commonly affected (P = 0.003). In addition, the plasma aldosterone concentration (PAC) was lower, plasma renin activity (PRA) higher, and hypokalemia (P < 0.001) less frequent than in sporadic cases. Except for a younger age (P < 0.001) and higher diastolic blood pressure (P = 0.006), the clinical and hormonal profiles of FH-II and sporadic cases were similar. FH-III had a distinct phenotype, with higher PAC and higher frequency of hypokalemia (P < 0.001), and presented 45 years before sporadic cases. Nevertheless, the clinical and hormonal phenotypes of FH-IV and sporadic cases were similar, with the former being younger and having lower serum potassium levels. Conclusion: In addition to being younger and having a family history of PA, FH-I and III share other typical characteristics. In this regard, FH-I is characterized by a low prevalence of hypokalemia and FH-III by a severe aldosterone excess causing hypokalemia in more than 85% of patients. The clinical and hormonal phenotype of type II and IV is similar to the sporadic cases.

Keywords

Chimeric cyp11b1/cyp11b2 geneDiagnosiFamilial hyperaldosteronismGenetic studyGlucocorticoid-remediable aldosteronismHyperaldosteronism type-iiHypertensionMutationNormotensive individualsOverproductionPathogenic variantPhenotypePlasma aldosterone concentratioPlasma aldosterone concentrationPrevalencePrimary aldosteronism

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Frontiers in Endocrinology due to its progression and the good impact it has achieved in recent years, according to the agency Scopus (SJR), it has become a reference in its field. In the year of publication of the work, 2024 there are still no calculated indicators, but in 2023, it was in position , thus managing to position itself as a Q1 (Primer Cuartil), in the category Endocrinology, Diabetes and Metabolism.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2025-08-05:

  • WoS: 2
  • Scopus: 1

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-08-05:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 10.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 13 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 6.2.
  • The number of mentions on the social network X (formerly Twitter): 12 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
  • Assignment of a Handle/URN as an identifier within the deposit in the Institutional Repository: https://repositorio.uam.es/handle/10486/715056